论文部分内容阅读
目的:分析急性ST段抬高型心肌梗死患者行瑞替普酶针溶栓疗法的临床效果。方法:调查对象于2012年3月-2015年5月收治急性ST抬高型心肌梗死患者中挑选,将100例平均分成不同疗法组:对照组(尿激酶溶栓)、研究组(瑞替普酶针溶栓),溶栓治疗后评估疗效。结果:研究组患者预后的再通率高于对照组,P<0.05,有区别;研究组患者预后的并发症率低于对照组,P<0.05,有区别。结论:临床针对急性ST段抬高型心肌梗死患者行瑞替普酶针疗法作用突出,可改善症状,提高疗效,值得借鉴。
Objective: To analyze the clinical effect of reteplase thrombolysis in patients with acute ST-segment elevation myocardial infarction. Methods: The subjects were selected from patients with acute ST-elevation myocardial infarction who were treated in March 2012 to May 2015. 100 patients were equally divided into different treatment groups: the control group (urokinase thrombolysis), the study group Enzyme needle thrombolysis), thrombolytic therapy to assess the efficacy. Results: The recanalization rate of prognosis of study group was higher than that of control group, P <0.05, there was a difference; the complication rate of prognosis of study group was lower than that of control group, P <0.05. Conclusion: The clinical effect of reteplase acupuncture therapy in patients with acute ST-segment elevation myocardial infarction is outstanding, which can improve the symptoms and improve the curative effect.